Factors associated with increased hospital utilization in patients with heart failure and preserved ejection fraction

Pharmacotherapy

Volumn 30, Issue 7, 2010, Pages 646-653

  Crowder, Rachel S ^a   Irons, Brian K ^b   Meyerrose, Gary ^a   Seifert, Charles F ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Diastolic heart failure; Heart failure; Hospital utilization; Outpatient predictors; PEF; Preserved ejection fraction; Pulse pressure; Racial differences; SBP; Systolic blood pressure

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART RATE; HOSPITAL UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE; AFRICAN AMERICAN; ANCESTRY GROUP; BLOOD PRESSURE; DRUG EFFECTS; HISPANIC; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VITAL SIGN;

ADULT; AFRICAN AMERICANS; AMBULATORY CARE FACILITIES; BLOOD PRESSURE; CONTINENTAL POPULATION GROUPS; FEMALE; HEART FAILURE; HISPANIC AMERICANS; HUMANS; MALE; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VITAL SIGNS;

EID: 77954095991     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.30.7.646     Document Type: Article

References (23)

1. Abdelhafiz AH. Heart failure in older people: causes, diagnosis, and treatment. Age Ageing 2002;31:29-36.
2. Whellan DJ, Harrington C. Diastolic heart failure and continuous hemodynamic monitoring. Am Heart J 2007;153:S6-11.
3. Fang J, Mensah GA, Croft JB, Keenan NL. Heart failure-related hospitalization in the U.S., 1979-2004. J Am Coll Cardiol 2008;52:428-34.
4. Cinnaiyan KM, Alexander D, Maddens M, McCullough PA. Curriculum in cardiology: integrated diagnosis and management of diastolic heart failure. Am Heart J 2007;153:189-200.
5. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-9.
6. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006;355:260-9.
7. Tsujino T, Kawasaki D, Masuyama T. Left ventricular diastolic dysfunction in diabetic patients: pathophysiology and therapeutic implications. Am J Cardiovasc Drugs 2006;6:219-30.
8. Lloyd-Jones D, Adams R, Carnethon M, et al, for the Writing Group Members. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee - chapter 8: heart failure. Circulation 2009;119:e101-4.
9. Satpathy C, Mishra TK, Satpathy R, Satpathy HK, Barone E. Diagnosis and management of diastolic dysfunction and heart failure. Am Fam Physician 2006;73:841-6.
10. Feld Y, Dubi S, Reisner Y, Schwammenthal E, Elami A. Future strategies for the treatment of diastolic heart failure. Acute Card Care 2006;8:13-20.
11. Flather MD, Shibata MC, Coats AJS, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005;26:215-25.
12. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial. Lancet 2003;362:777-81.
13. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33.
14. Cleland JGF, Tendra M, Adamus J, Freemantle N, Polonski L, Taylor J. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006;27:2338-45.
15. Aronow WS, Ahn C, Kronzon I. Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left-ventricular ejection fraction ≥ 40% treated with diuretics plus angiotensin-converting enzyme inhibitors. Am J Cardiol 1997;80:207-9.
16. Fukuta H, Sane DC, Brucks S, Little WC. Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report. Circulation 2005;112:357-63.
17. Philbin EF, Rocco TA, Lindenmuth NW, Ulrich K, Jenkins PL. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 2000;109:605-13.
18. Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008;359:2456-67.
19. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. Circulation 2001;104:2996-3007.
20. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults. Circulation 2009;119:1977-2016.
21. Klapholz M, Maurer M, Lowe AM, et al. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York heart failure registry. J Am Coll Cardiol 2004;43:1432-8.
22. Vaccarino V, Holford TR, Krumholz HM. Pulse pressure and risk for myocardial infarction and heart failure in the elderly. J Am Coll Cardiol 2000;36:130-8. (Pubitemid 30466123)
23. Bibbins-Domingo K, Pletcher MJ, Lin F, et al. Racial differences in incident heart failure among young adults. N Engl J Med 2009;360:1179-90.